Image 1
Chemical structure of Orphenadrine Citrate showing its molecular formula C18H23NO.C6H8O7 and molecular weight 461.51.*
Orphenadrine Citrate Injection
Product Images NDC 0591-3222
2 FDA label images from Actavis Pharma, Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 0591-3222). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
Orphenadrine Citrate Injection, USP 60 mg/2 mL (30 mg/mL) sterile ampules packaging label. The label shows the product is for intravenous or intramuscular use, offered in 10 ampules of 2 mL each. It is manufactured by Hikma Farmaceutica in Portugal and distributed by Actavis Pharma, Inc. Contains storage and dosing instructions, and lists inactive ingredients used for pH adjustment.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
